IDEAYA Announces Agenda for Investor RD Day Webcast on December 16, 2024
IDYA Stock | USD 18.58 0.55 2.88% |
About 64% of Ideaya Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Ideaya Biosciences suggests that many traders are alarmed. The current market sentiment, together with Ideaya Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ideaya Biosciences stock news signals to limit their universe of possible portfolio assets.
Ideaya |
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced agenda topics for its virtual Investor RD Day. The webcast event will be hosted by IDEAYA on Monday, December 16, 2024 at 800 am to 930 am ET.
Read at finance.yahoo.com
![]() |
Ideaya Biosciences Current Investor Sentiment
Comfort Level 36
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ideaya Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ideaya Biosciences.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentDisposing |
Ideaya Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Ideaya Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ideaya Biosciences Historical Investor Sentiment
Investor biases related to Ideaya Biosciences' public news can be used to forecast risks associated with an investment in Ideaya. The trend in average sentiment can be used to explain how an investor holding Ideaya can time the market purely based on public headlines and social activities around Ideaya Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ideaya Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ideaya Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ideaya Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Ideaya Biosciences.
Ideaya Biosciences Fundamental Analysis
We analyze Ideaya Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ideaya Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ideaya Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Ideaya Biosciences is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Ideaya Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ideaya Biosciences stock to make a market-neutral strategy. Peer analysis of Ideaya Biosciences could also be used in its relative valuation, which is a method of valuing Ideaya Biosciences by comparing valuation metrics with similar companies.
Peers
Ideaya Biosciences Related Equities
KROS | Keros Therapeutics | 4.41 | ||||
VTYX | Ventyx Biosciences | 2.08 | ||||
VRNA | Verona Pharma | 0.89 | ||||
MLTX | MoonLake Immunotherapeuti | 0.78 | ||||
MGTX | MeiraGTx Holdings | 0.46 | ||||
AMLX | Amylyx Pharmaceuticals | 0.33 | ||||
ABOS | Acumen Pharmaceuticals | 0.00 | ||||
TERN | Terns Pharmaceuticals | 0.00 | ||||
INZY | Inozyme Pharma | 0.00 | ||||
PTGX | Protagonist Therapeutics | 0.18 | ||||
RNA | Avidity Biosciences | 0.99 | ||||
RVMD | Revolution Medicines | 1.77 | ||||
SWTX | SpringWorks Therapeutics | 2.89 | ||||
DAWN | Day One | 4.97 | ||||
SNDX | Syndax Pharmaceuticals | 7.56 | ||||
XFOR | X4 Pharmaceuticals | 8.60 | ||||
ANAB | AnaptysBio | 9.39 |
Complementary Tools for Ideaya Stock analysis
When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |